Table 1 Characteristics of the study subjects
Characteristics | Total (n = 402) | Men (n = 240) | Women (n = 162) | p value |
|---|---|---|---|---|
Age, years | 51.12 ± 11.95 | 49.86 ± 11.60 | 52.99 ± 12.26 | 0.010 |
BMI/(kg/m2) | 25.50 ± 4.00 | 26.05 ± 3.74 | 24.69 ± 4.23 | 0.001 |
Waist (cm) | 90.46 ± 10.67 | 93.69 ± 8.73 | 85.48 ± 11.32 | < 0.001 |
Glucose (mmol/L) | 5.76 ± 1.78 | 5.80 ± 1.76 | 5.68 ± 1.81 | 0.504 |
Triglycerides (mmol/L) | 1.95 ± 1.30 | 2.15 ± 1.41 | 1.66 ± 1.05 | < 0.001 |
Total cholesterol (mmol/L) | 4.91 ± 1.04 | 4.80 ± 1.00 | 5.08 ± 1.10 | 0.007 |
LDL-C (mmol/L) | 3.27 ± 0.80 | 3.20 ± 0.72 | 3.38 ± 0.88 | 0.036 |
HDL-C (mmol/L) | 1.19 ± 0.44 | 1.09 ± 0.40 | 1.35 ± 0.45 | < 0.001 |
ALT (IU/L) | 24 (16–36) | 28 (19–38) | 18 (13–29) | 0.003 |
AST (IU/L) | 23 (19–29) | 23 (20–29) | 22 (18–28) | 0.876 |
γ-GT (IU/L) | 28 (18–46) | 33 (22–51) | 19 (13–33) | < 0.001 |
Creatinine (μmol/L) | 77.11 ± 16.35 | 84.37 ± 16.42 | 66.42 ± 8.53 | < 0.001 |
eGFR (mL/min·1.73 m2) | 90.00 ± 15.76 | 91.32 ± 17.02 | 88.06 ± 13.50 | 0.043 |
PSP (mmHg) | 132.59 ± 17.99 | 133.19 ± 15.90 | 131.70 ± 20.72 | 0.415 |
PDP (mmHg) | 77.50 ± 12.33 | 78.64 ± 11.95 | 75.82 ± 12.72 | 0.024 |
PP (mmHg) | 55.09 ± 13.07 | 54.55 ± 11.91 | 55.88 ± 14.64 | 0.320 |
MAP (mmHg) | 95.86 ± 13.08 | 96.82 ± 12.16 | 94.45 ± 14.26 | 0.074 |
cfPWV | 8.23 ± 1.86 | 8.33 ± 1.88 | 8.08 ± 1.82 | 0.187 |
HR | 70.37 ± 10.56 | 69.72 ± 9.97 | 71.34 ± 11.33 | 0.132 |
FLI | 45 (20–71) | 57 (33–77) | 36 (11–52) | < 0.001 |